Shoved off schedule by a nasty recession, New York is looking to put its huge new biotech facility for early-stage developers back on track with plans to break ground soon on the first 100,000 square feet of space at the Brooklyn Army Terminal.
BioBAT is New York's answer to a commonly asked question: Why doesn't the city, home to some of the most acclaimed scientists in the medical field, play host to a booming biotech industry? Lack of affordable space for start-ups is...